Part

Guardant Health and The Royal Marsden NHS Foundation Trust partner on highly anticipated TRACC Part C trial to use Guardant Reveal™ blood test to help guide treatment decisions in colorectal cancer

Retrieved on: 
Thursday, January 19, 2023

The trial is intended to determine whether patients can be spared unnecessary chemotherapy and the associated side effects if they test negative for ctDNA using the Guardant Reveal™ blood test following surgery.

Key Points: 
  • The trial is intended to determine whether patients can be spared unnecessary chemotherapy and the associated side effects if they test negative for ctDNA using the Guardant Reveal™ blood test following surgery.
  • The study will use the Guardant Reveal blood test to detect MRD by measuring the DNA shed from tumor cells into the bloodstream.
  • “Patients with high-risk colorectal cancer are often over-treated and can suffer long-term neurotoxicity from chemotherapy,” said Professor David Cunningham, director of clinical research at The Royal Marsden NHS Foundation Trust, chief investigator for the TRACC Part C study.
  • The Royal Marsden NHS Foundation Trust announced that the first patient was enrolled in TRACC Part C in September 2022.

Cadmatic is Part of Consortium Leading EU-Funded SEUS Project for Smarter and More Productive Shipbuilding

Retrieved on: 
Thursday, January 12, 2023

Cadmatic is part of a consortium of industrial companies and academic institutions that is leading the EU-funded Smart European Shipbuilding project (SEUS) that was launched 1 January 2023.

Key Points: 
  • Cadmatic is part of a consortium of industrial companies and academic institutions that is leading the EU-funded Smart European Shipbuilding project (SEUS) that was launched 1 January 2023.
  • View the full release here: https://www.businesswire.com/news/home/20230111005065/en/
    Cadmatic is Part of Consortium Leading EU-Funded SEUS Project for Smarter and More Productive Shipbuilding (Photo: Business Wire)
    The platform solution aims to slash the time needed for ship engineering by 30% and cut assembly times by an ambitious 20%.
  • Cadmatic is responsible for leading the technical coordination of the four-year-long SEUS project.
  • “We are proud to be leading the technical coordination and working alongside the other consortium partners on this ambitious project.

University of Phoenix Chief Operating Officer Raghu Krishnaiah featured on “The Balancing Act” podcast

Retrieved on: 
Tuesday, January 10, 2023

Raghu Krishnaiah, chief operating officer of the University of Phoenix was a featured guest of “The Balancing Act” podcast, in an episode dedicated to how organizational leaders should approach data literacy as a skill.

Key Points: 
  • Raghu Krishnaiah, chief operating officer of the University of Phoenix was a featured guest of “The Balancing Act” podcast, in an episode dedicated to how organizational leaders should approach data literacy as a skill.
  • The podcast episode with Krishnaiah, “The Skill of Data Literacy, Part 2,” was released on December 22, 2022, and features insights from Krishnaiah and podcast host Dr. Andrew Temte, CFA, discussing how leadership and specifically the role of chief operating officer can be critical to promoting data literacy as a skill throughout an organization.
  • “The COO needs to talk about the power and benefits that you can get from becoming data savvy and be an advocate for data literacy,” shares Krishnaiah.
  • As the Chief Operating Officer at University of Phoenix, Krishnaiah is instrumental in the transformation of the University and responsible for all operating strategy and results.

Wejo Group Limited Enters Into Business Combination with TKB Critical Technologies 1

Retrieved on: 
Tuesday, January 10, 2023

Wejo Group Limited (NASDAQ:WEJO) (“Wejo”), a global leader in Smart Mobility for Good™ cloud and software analytics for connected, electric and autonomous mobility, today announced that it has entered into a definitive business combination agreement to combine with TKB Critical Technologies 1 (NASDAQ: USCT) (“TKB”).

Key Points: 
  • Wejo Group Limited (NASDAQ:WEJO) (“Wejo”), a global leader in Smart Mobility for Good™ cloud and software analytics for connected, electric and autonomous mobility, today announced that it has entered into a definitive business combination agreement to combine with TKB Critical Technologies 1 (NASDAQ: USCT) (“TKB”).
  • The proposed business combination is structured as a stock-for-stock merger, whereby each of Wejo and TKB will become wholly owned subsidiaries of a new holding company (“Wejo Holdings”).
  • TKB Critical Technologies 1 is a blank check company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
  • TKB is dedicated to investing in critical technologies and the resources needed to manufacture those technologies for America and our allied nations.

Fifth Third Bank Opens San Diego Commercial Banking Office

Retrieved on: 
Tuesday, January 10, 2023

Fifth Third Bank, National Association, today announced the opening of its fifth commercial banking office in California with a new location in San Diego.

Key Points: 
  • Fifth Third Bank, National Association, today announced the opening of its fifth commercial banking office in California with a new location in San Diego.
  • Located in Carmel Valley, the office covers San Diego County and is staffed by a locally based team with a longstanding history in the region.
  • “At Fifth Third, we look to be the banking partner of choice,” said Kevin Lavender, head of commercial banking at Fifth Third Bank.
  • Fifth Third’s San Diego office is managed by Jim Kordas, senior vice president, middle market executive, who brings more than 20 years of banking experience to his role.

Kohl’s Hometown Giving Program Donates More Than $500,000 to Nonprofits Serving Milwaukee and Waukesha Counties

Retrieved on: 
Tuesday, January 10, 2023

“The Ability Center's Open Gym program provides an atmosphere where all can feel welcome, wanted and comfortable.

Key Points: 
  • “The Ability Center's Open Gym program provides an atmosphere where all can feel welcome, wanted and comfortable.
  • The Friends of Retzer try to help the Nature Center in all its activities and efforts.
  • “This grant is going to help fund our Artists-In-Residence program and youth art show, which happens once a year.
  • For our housing program, we have about 40 slots and, at any given time, there’s about 200 young people on our waiting list.

Johnson Controls Acquires Hybrid Energy to Enhance Industrial Heat Pump Portfolio

Retrieved on: 
Friday, January 13, 2023

"Hybrid Energy is well positioned in its ability to deliver extremely high-temperature process heating while maintaining energy efficiency – and with the reach and resources of Johnson Controls, we will be able to solve the challenges of more customers.

Key Points: 
  • "Hybrid Energy is well positioned in its ability to deliver extremely high-temperature process heating while maintaining energy efficiency – and with the reach and resources of Johnson Controls, we will be able to solve the challenges of more customers.
  • Hybrid Energy, based in Lysaker, Norway, will add to the ability of Johnson Controls to address high-temperature heating requirements with a hybrid heat pump as its core.
  • "Between Hybrid Energy's unique heat pump technologies, the reach and capability of Johnson Controls and the collective brain power from both, we'll help advance a sustainable future by setting the standard for high-temperature industrial heat pumps."
  • Johnson Controls International plc has made statements in this communication regarding the acquisition of Hybrid Energy that are forward-looking and therefore are subject to risks and uncertainties.

Berry Aviation, Inc. New Hire Announcement - Vice President of Unmanned Aerial Systems Division

Retrieved on: 
Thursday, January 12, 2023

SAN MARCOS, Texas, Jan. 12, 2023 /PRNewswire/ -- Berry Aviation, Inc. is pleased to announce the expansion of their executive leadership team by welcoming Tom Ballenger as Vice President of its Unmanned Aerial Systems (UAS) group.

Key Points: 
  • SAN MARCOS, Texas, Jan. 12, 2023 /PRNewswire/ -- Berry Aviation, Inc. is pleased to announce the expansion of their executive leadership team by welcoming Tom Ballenger as Vice President of its Unmanned Aerial Systems (UAS) group.
  • Tom is responsible for the oversight, management, and execution of Berry Aviation's UAS contracts, delivering warfighter capability and customer support excellence.
  • Additionally, Tom will spearhead capability development in UAS, emerging threat replication and unmanned ISR & cargo services for Berry clients.
  • Stan Finch, President of Berry Aviation said, "We're very fortunate to bring Tom onboard and look forward to benefiting from his business, senior program management, and defense aviation expertise.

SpotLite360 IOT Solutions, Inc. Announces Private Placement

Retrieved on: 
Friday, January 13, 2023

The Offering is expected to close on or about January 19, 2023.

Key Points: 
  • The Offering is expected to close on or about January 19, 2023.
  • Dr. Eddie Shek is a technology advisor and executive coach helping technology companies build software products effectively and efficiently.
  • He is co-founder of and has served in Chief Technology Officer and Chief Strategy Officer roles at TrackX, Inc. (TSX.V:TKX).
  • The Company would like to thank Messrs. Dumaresq, Somjen and Phillips for their contributions to the Company and wishes them well with their future endeavors.

MediciNova Announces Completion of Enrollment in the Phase 2 Clinical Trial Evaluating MN-166 (ibudilast) for Treatment of Recurrent and Newly Diagnosed Glioblastoma

Retrieved on: 
Thursday, January 12, 2023

This Phase 1/2 clinical trial was divided into a dose-escalation phase (Part 1) followed by a fixed-dose phase (Part 2).

Key Points: 
  • This Phase 1/2 clinical trial was divided into a dose-escalation phase (Part 1) followed by a fixed-dose phase (Part 2).
  • Part 2 will evaluate the efficacy of MN-166 (ibudilast) and TMZ combination treatment.
  • We evaluated the correlation of MN-166 and TMZ combination therapy to clinical outcomes and tumor tissue analysis findings.
  • Kazuko Matsuda, MD, PhD, MPH, Chief Medical Officer of MediciNova, Inc., commented, "We have completed enrollment and are actively treating the remaining patients in Part 2 of the trial.